Mellor-Pita, S.; Tutor-Ureta, P.; Velasco, P.; Plaza, A.; Diego, I.; Vázquez-Comendador, J.; Vionnet, A.P.; Durán-del Campo, P.; Moreno-Torres, V.; Vargas, J.A.;
et al. IgA Anti-β2-Glycoprotein I Antibodies as Markers of Thrombosis and Severity in COVID-19 Patients. Viruses 2024, 16, 1071.
https://doi.org/10.3390/v16071071
AMA Style
Mellor-Pita S, Tutor-Ureta P, Velasco P, Plaza A, Diego I, Vázquez-Comendador J, Vionnet AP, Durán-del Campo P, Moreno-Torres V, Vargas JA,
et al. IgA Anti-β2-Glycoprotein I Antibodies as Markers of Thrombosis and Severity in COVID-19 Patients. Viruses. 2024; 16(7):1071.
https://doi.org/10.3390/v16071071
Chicago/Turabian Style
Mellor-Pita, Susana, Pablo Tutor-Ureta, Paula Velasco, Aresio Plaza, Itziar Diego, José Vázquez-Comendador, Ana Paula Vionnet, Pedro Durán-del Campo, VÃctor Moreno-Torres, Juan Antonio Vargas,
and et al. 2024. "IgA Anti-β2-Glycoprotein I Antibodies as Markers of Thrombosis and Severity in COVID-19 Patients" Viruses 16, no. 7: 1071.
https://doi.org/10.3390/v16071071
APA Style
Mellor-Pita, S., Tutor-Ureta, P., Velasco, P., Plaza, A., Diego, I., Vázquez-Comendador, J., Vionnet, A. P., Durán-del Campo, P., Moreno-Torres, V., Vargas, J. A., & Castejon, R.
(2024). IgA Anti-β2-Glycoprotein I Antibodies as Markers of Thrombosis and Severity in COVID-19 Patients. Viruses, 16(7), 1071.
https://doi.org/10.3390/v16071071
